Protalix BioTherapeutics
PLX
#8447
Rank
C$0.23 B
Marketcap
$3.22
Share price
3.23%
Change (1 day)
57.30%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -C$10.4 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$45.66 Million. In 2023 the company made an earning of C$16.89 Million, an increase over its 2022 earnings that were of -C$17.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$10.4 Million-161.5%
2023 C$16.89 M-199.05%
2022 -C$17.06 Million-40.38%
2021 -C$28.62 Million-732.31%
2020 C$4.52 M-130.53%
2019 -C$14.82 Million189.85%
2018 -C$5.12 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$26.61 Million-32.37%
2015 -C$39.35 Million10.11%
2014 -C$35.73 Million-7.59%
2013 -C$38.67 Million
2011 -C$44.78 Million-19.39%
2010 -C$55.55 Million20.87%
2009 -C$45.96 Million32.26%
2008 -C$34.75 Million-5.46%
2007 -C$36.75 Million
2004 -C$0.24 Million12.35%
2003 -C$0.22 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.56 Million1.03%
2000 -C$0.55 Million-53.22%
1999 -C$1.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$41.34 Million 270.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.73 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.97 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.41 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel